Phase III clinical trial 2 articles

Phase III clinical trial denotes a large confirmatory clinical development stage designed to establish benefit-risk evidence with a specific role in clinical development and regulated biomedical research. A typical implementation combines confirmatory clinical study with large patient population trial, with pivotal efficacy evaluation shaping the resulting molecular, cellular or analytical outcome. Phase III is the confirmatory development stage and is distinct from Phase II exploratory efficacy work or post-approval evidence generation.